This article provides a comprehensive analysis of the challenge of poor endometrial response in HRT cycles, a significant barrier to success in assisted reproduction.
This article provides a comprehensive analysis of progestogen-related side effects in combined Hormone Replacement Therapy (HRT), addressing a critical challenge in women's health therapeutics.
This article provides a comprehensive analysis for researchers and drug development professionals on optimizing Hormone Replacement Therapy (HRT) for postmenopausal women with type 2 diabetes (T2DM).
This article provides a comprehensive analysis of Hormone Replacement Therapy's (HRT) role in addressing menopausal weight gain for researchers and drug development professionals.
This article provides a comprehensive framework for researchers and drug development professionals on optimizing Hormone Replacement Therapy (HRT) dosing for vasomotor symptom (VMS) control.
This article synthesizes current evidence and identifies strategic approaches to overcome the multifaceted challenge of non-adherence and non-persistence in Hormone Replacement Therapy (HRT).
Breakthrough bleeding (BTB) is the most common cause of discontinuation of menopausal hormone therapy (MHT), presenting a significant challenge for patient adherence and therapeutic efficacy.
This article provides a comprehensive analysis of transdermal estrogen delivery systems and their pivotal role in minimizing venous thromboembolism (VTE) risk associated with menopausal hormone therapy.
This article provides a comprehensive overview of modern analytical techniques for assessing hormone bioavailability across diverse formulations.
This article addresses the critical lack of standardized protocols for compounded bioidentical hormone replacement therapy (cBHT), a significant challenge in regulatory science and pharmaceutical development.